ATCC Cell-Specific Exosomes

ATCC has launched a portfolio of human-derived exosomes to serve as reference materials or standards for a variety of research applications. The firm's first two exosomes available are dervied from the A549 non-small cell lung cancer (NSCLC) cell line and hTERT-immortalized mesenchymal stem cells.